Rani Therapeutics Holdings, Inc.
Pharmaceutical Preparations · SAN JOSE · CA
Moderate confidence (50%)
Updated Oct 14, 2026, 12:01 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: Rani Therapeutics Holdings, Inc. received a delisting notice from its exchange (May 11, 2026)
Timeline
Every material event, newest first. History is never overwritten.
Rani Therapeutics Holdings, Inc. received a delisting notice from its exchange
May 11, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 11, 2026, the Company received a letter from the Nasdaq Stock Exchange LLC ( Nasdaq ), notifying the Company that, based on the closing bid price of the Company s Class A common stock, par value $0.0001 per share (the Common Stock ), for the prior 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker RANI on Nasdaq.
- SEC CIK
- 0001856725
- Website
- —
- —
- Headquarters
- SAN JOSE, CA
- Also known as
- —
- Legal entities
- Rani Therapeutics Holdings, Inc.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
Rani Therapeutics Holdings, Inc. — Pharmaceutical Preparations (SIC 2834) — SAN JOSE, CA
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On May 11, 2026, the Company received a letter from the Nasdaq Stock Exchange LLC ( Nasdaq ), notifying the Company that, based on the closing bid price of the Company s Class A common stock, par value $0.0001 per share (the Common Stock ), for the prior 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on The Nasdaq Global Market. Nasdaq Listing Rule 5450(a)(1) requires listed securities to maintain a minimum bid…
View source record
Status history
Every derived status, with the rule that produced it.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:29 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 18, 2026, 01:11 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 15, 2026, 12:33 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- DISTRESS_SIGNAL → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 14, 2026, 04:44 PM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
- UNKNOWN → DISTRESS_SIGNALPUBLIC_LISTING_ENDED · Sep 8, 2026, 04:40 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.